Back

Yuanhua Medtech raises NT$270 million ahead of 2027 listing

Verifying
  • Yuanhua Medtech completed a NT$270 million cash capital increase with external investors.
  • NT$270 million will fund AI and biotech research, platform upgrades and expanded collaborations.
  • Yuanhua Medtech moved beyond wholly owned status as it prepares for a 2027 listing.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.